Nathan Caffo's Insider Trades & SAST Disclosures
Nathan Caffo's most recent trade in Candel Therapeutics Inc was a trade of 6,000 Common Stock done at an average price of $8 . Disclosure was reported to the exchange on July 29, 2021.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Nathan Caffo.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Candel Therapeutics Inc | Nathan Caffo | Chief Business Officer | Purchase of securities on an exchange or from another person at price $ 8.00 per share. | 29 Jul 2021 | 6,000 | 6,000 | - | 8 | 48,000 | Common Stock |
| Alx Oncology Holdings Inc | Nathan Caffo | Chief Business Officer | 21 Jul 2020 | 10,529 | 11,254 | - | - | Common Stock | ||
| Alx Oncology Holdings Inc | Nathan Caffo | Chief Business Officer | 21 Jul 2020 | 10,529 | 0 | - | - | Series B Convertible Preferred Stock | ||
| Alx Oncology Holdings Inc | Nathan Caffo | Chief Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jul 2020 | 22,794 | 22,794 | - | - | Employee Stock Option (right to buy) |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges